Both in Pharmaceuticals
Biote vs Grace Therapeutics
Over the past year BTMD returned −60.0% and GRCE returned −44.1%; their daily moves had a correlation of 0.07.
BTMD −60.0% GRCE −44.1%Growth of $1, one year, split-adjusted
| Metric | BTMD | GRCE |
|---|---|---|
| Price | $1.16 | $1.76 |
| Market cap | $33.3M | $37.0M |
| Today | +8.41% | −8.81% |
| 1 month | −4.9% | −17.0% |
| 6 months | −48.9% | −18.5% |
| Year to date | −55.4% | −49.1% |
| 1 year | −60.5% | −44.1% |
| Revenue growth (YoY) | −9.5% | — |
| Gross margin | 65.4% | — |
| Net margin | −14.8% | — |
| P/E (TTM) | 5.7× | — |
| Price / sales | 0.2× | — |
| Net cash | -$110.3M | $13.8M |
| Dividend yield | — | — |
| Volatility (60d) | 95.0% | 41.0% |
| Short % of float | 5.0% | 11.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).